Systematic Review: Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension.
15 Jun, 2022 | 10:30h | UTCRho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension – Cochrane Library
Summary: Rho kinase inhibitors for primary open-angle glaucoma and ocular hypertension – Cochrane Library